First test of Fat-Derived stem cells for debilitating muscle disease

NCT ID NCT04975841

Summary

This small, early-stage study tested whether stem cells taken from a patient's own fat tissue could be safely injected into the muscles of people with Inclusion Body Myositis (IBM). IBM is a progressive disease that causes severe muscle weakness, especially in the thighs and hands, and has no effective treatment. The main goal was to check for safety, with the hope that if safe, the injections might one day help slow or stabilize the muscle weakness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INCLUSION BODY MYOSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

Conditions

Explore the condition pages connected to this study.